Related Experiment Videos
PUMA in head and neck cancer
Mohammad Obaidul Hoque1, Shahnaz Begum, Matthias Sommer
1Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins School of Medicine, Ross Research Building, Room 818, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.
Cancer Letters
|September 10, 2003
Summary
The PUMA gene, a key player in apoptosis, was investigated in head and neck and lung cancers. Despite its tumor-suppressing role, PUMA mutations were not found, suggesting it
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TP53 gene alterations are crucial in human cancer development, regulating DNA damage and cellular checkpoints.
- PUMA, a direct mediator of p53-induced apoptosis, has been identified as a significant factor in cancer.
- The PUMA gene is located on chromosomal arm 19q, a region often deleted in head and neck and lung cancers.
Purpose of the Study:
- To investigate the role of the PUMA gene in head and neck and lung tumorigenesis.
- To analyze for loss of heterozygosity (LOH) at the 19q chromosomal region in primary tumors.
- To identify potential PUMA gene mutations in cancer samples and assess its functional impact.
Main Methods:
- Loss of heterozygosity (LOH) analysis at 19q using seven microsatellite markers in 30 primary tumors (15 head/neck, 15 lung).
- Sequencing of the entire PUMA gene coding region in 30 primary tumors and 10 head/neck cancer cell lines.
- Functional assessment of PUMA's tumor-suppressive activity via forced expression in head/neck cancer cell lines.
Main Results:
- LOH at 19q was observed in 56% of head and neck and 26.6% of lung cancer samples.
- D19S408 and D19S412 markers showed the highest allelic loss rates (23.3% and 16.6%, respectively).
- No PUMA gene mutations were detected in any of the examined tumor samples or cell lines.
- Forced expression of wild-type PUMA significantly inhibited colony formation in head/neck cancer cell lines.
Conclusions:
- PUMA exhibits tumor-suppressive activity in head and neck cancers.
- Despite its functional role, PUMA does not appear to be directly inactivated through mutation in head and neck tumorigenesis.
- Further research is needed to elucidate the precise mechanisms of PUMA's involvement in cancer development.